JRD-SIK1/2i-4 |
JRD-SIK1/2i-4 : Inhibitor of SIK1, SIK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SIK1 |
| |
| SIK2 |
|
|
Inhibitor
5 -10 µM
up to 5 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within target family: SIK isoform selectivity was assessed in SIK1, SIK2, and SIK3 ADP-G ...
Potency Cellular
In Vitro
SIK1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1073/pnas.2307086120
SIK2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1073/pnas.2307086120
In Vivo Validations
Rat
Dose: 1 mg/Kg IV, 5 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
59 mL/min/Kg (IV)
Bioavailability:
60% (PO)
Volume of Distribution at Steady-State:
4.0 L/Kg (IV)
DOI Reference: 10.1073/pnas.2307086120
Chemical Information
| Molecular Formula | C21H20N6O2 |
| SMILEs | CN1CC(Oc2cnc(C#N)cc2-c2ccn3nc(NC(=O)C4CC4)cc3c2)C1 |
| InChI | InChI=1S/C21H20N6O2/c1-26-11-17(12-26)29-19-10-23-15(9-22)7-18(19)14-4-5-27-16(6-14)8-20(25-27)24-21(28)13-2-3-13/h4-8,10,13,17H,2-3,11-12H2,1H3,(H,24,25,28) |
| Molecular weight | 388.16 Da |
| AlogP | 0.0 |
| HBond acceptors | 8 |
| HBond donors | 1 |
| Atoms | 49 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.